CTRI/2020/06/026118尚未招募未知
Evaluation of Antiphospholipid Antibody (APA) in COVID-19 Cases.
DR Rajlaxmi Sarangi0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Cases: All RT-PCR positive COVID 19 cases admitted to KIMS COVID hospital.
- •Control: Age and Gender matched apparently healthy Individuals
排除标准
- •RT-PCR positive COVID 19 cases but donot haveRecent Surgery
- •Hypertension, CAD, CKD, CLD, Malignancies
- •Obesity, smoking
- •Associated systemic autoimmune diseases
- •Estrogen intake
- •Chronic steroid therapy
- •Use of anticoagulant medications , vitamin K antagonists.
研究者
相似试验
招募中
不适用
AntiPhosphoLipid antibodies and point-of-care INR measurement with CoaguChek - VervOlg Studie100644771000381610014523Antiphospholipid syndromeNL-OMON56632niversitair Medisch Centrum Utrecht44
尚未招募
不适用
The influence of antiphospholipid antibodies on INR values measured with the CoaguChek XSNL-OMON21805Dutch Thrombosis Foundation80
已完成
不适用
The influence of antiphospholipid antibodies on INR values measured with the CoaguChek XSNL-OMON51121niversitair Medisch Centrum Utrecht80
进行中（未招募）
不适用
Antiphospholipid antibodies testing and pregnancy outcomes in recurrent implantation failure women, is it necessary?Recurrent implantation failure womenRecurrent implantation failureAntiphospholipid antibodiesICSITCTR20231003007/A250
Unknown
不适用
Ankylosing Spondylitis and Antiphospholipid AntibodiesAnkylosing SpondylarthritisNCT02809300CHU de Reims80